statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response PR Newswire...

As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response

Oncolytics Biotech to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights Oncolytics Biotech to Host Conference Call to Discuss First Quarter Financial...

Oncolytics Biotech to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights

Oncolytics Biotech Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting Oncolytics Biotech Announces Upcoming Presentations at the American Society of Clinical...

Oncolytics Biotech Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting

Biotech Innovations Paving the Way in Breast Cancer Fight Biotech Innovations Paving the Way in Breast Cancer Fight PR Newswire VANCOUVER, BC, April 11, 2024 FN Media Group Presents USA News Group...

Biotech Innovations Paving the Way in Breast Cancer Fight

Oncolytics Biotech Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA Oncolytics Biotech Advances Toward...

Oncolytics Biotech Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA

Analysts at Raymond James assumed coverage on shares of Oncolytics Biotech (NASDAQ:ONCY - Get Free Report) in a research note issued on Thursday, Benzinga reports. The brokerage set an "outperform...

Oncolytics Biotech (NASDAQ:ONCY) Now Covered by Raymond James

Oncolytics Biotech (TSE:ONC) has released an update. Oncolytics Biotech Inc., a leader in the field of immunotherapeutic cancer treatments, is slat...

Oncolytics Biotech Showcases at Oncology Conference

Oncolytics Biotech to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual Conference Oncolytics Biotech to Participate in a Panel Presentation at Canaccord...

Oncolytics Biotech to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual Conference

Biotech's Role in Addressing the Pancreatic Cancer Emergency Biotech's Role in Addressing the Pancreatic Cancer Emergency PR Newswire VANCOUVER, BC, March 14, 2024 FN Media Group Presents USA News...

Biotech's Role in Addressing the Pancreatic Cancer Emergency

Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.

Volume	85,974.00
52-Wk High	$3.39
52-Wk Low	$0.883

Period	Estimated	Reported	Surprise	Result
Q1'24	-$0.08	--	--	N/A
Q4'23	-$0.11	-$0.04	65.55%	BEAT
Q3'23	-$0.08	-$0.10	-29.74%	MISSED
Q2'23	-$0.09	-$0.09	-1.10%	MISSED
Q1'23	-$0.09	-$0.07	20.81%	BEAT

ONCY Oncolytics Biotech, Inc.

About

Feed

News

Earnings

Fundamentals